How tobacco rules could change smoking and health
Center for the Assessment of Tobacco Regulations (CAsToR) TCORS 3.0
This center uses computer models and national data to predict how FDA tobacco rules might change who uses cigarettes, e-cigarettes, cigars, and related products and how that affects heart health across the U.S.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11168760 on NIH RePORTER |
What this research studies
From my perspective as someone affected by tobacco, the team gathers current and historical data on tobacco use, health risks, and behavior for different groups. They run simulation models to show how different regulatory actions could change use patterns and long-term health outcomes. Experts fill gaps in data, compare multiple modeling approaches, and estimate benefits and harms at the population level, paying attention to differences by age, income, and other demographics. The goal is to provide clear information policymakers can use to weigh choices that might reduce tobacco-related disease.
Who could benefit from this research
Good fit: People who currently use cigarettes, e-cigarettes, cigars, or other tobacco products, and those at risk for tobacco-related cardiovascular disease, are the main groups whose experiences this work models.
Not a fit: Individuals seeking immediate medical treatment or personal therapies for heart disease will not receive direct clinical benefits from this population-level policy modeling.
Why it matters
Potential benefit: If successful, this work could help shape rules that lower tobacco use and prevent tobacco-related heart disease across communities.
How similar studies have performed: Previous tobacco simulation and policy-modeling efforts have informed FDA decisions and provided useful population-level predictions, though exact outcomes depend on policy details and behavior change.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Mendez Emilien, David — University of Michigan at Ann Arbor
- Study coordinator: Mendez Emilien, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.